AT329065B - Verfahren zur herstellung neuer piperazinderivate und ihrer salze - Google Patents

Verfahren zur herstellung neuer piperazinderivate und ihrer salze

Info

Publication number
AT329065B
AT329065B AT320373A AT320373A AT329065B AT 329065 B AT329065 B AT 329065B AT 320373 A AT320373 A AT 320373A AT 320373 A AT320373 A AT 320373A AT 329065 B AT329065 B AT 329065B
Authority
AT
Austria
Prior art keywords
salts
production
piperazine derivatives
new piperazine
new
Prior art date
Application number
AT320373A
Other languages
English (en)
Other versions
ATA320373A (de
Original Assignee
Cerm Cent Europ Rech Mauvernay
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cerm Cent Europ Rech Mauvernay filed Critical Cerm Cent Europ Rech Mauvernay
Publication of ATA320373A publication Critical patent/ATA320373A/de
Application granted granted Critical
Publication of AT329065B publication Critical patent/AT329065B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AT320373A 1972-04-13 1973-04-11 Verfahren zur herstellung neuer piperazinderivate und ihrer salze AT329065B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7212893A FR2173869B1 (de) 1972-04-13 1972-04-13

Publications (2)

Publication Number Publication Date
ATA320373A ATA320373A (de) 1975-07-15
AT329065B true AT329065B (de) 1976-04-26

Family

ID=9096779

Family Applications (1)

Application Number Title Priority Date Filing Date
AT320373A AT329065B (de) 1972-04-13 1973-04-11 Verfahren zur herstellung neuer piperazinderivate und ihrer salze

Country Status (14)

Country Link
US (1) US3884923A (de)
JP (1) JPS541316B2 (de)
AT (1) AT329065B (de)
BE (1) BE798067A (de)
CA (1) CA1019740A (de)
CH (1) CH570984A5 (de)
DE (2) DE2318025C2 (de)
ES (1) ES413487A1 (de)
FR (1) FR2173869B1 (de)
GB (1) GB1382559A (de)
IL (1) IL42030A (de)
NL (1) NL177113C (de)
OA (1) OA04927A (de)
ZA (1) ZA732457B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2472567A1 (fr) 1979-12-28 1981-07-03 Cerm Cent Europ Rech Mauvernay Ethers de 1- (2-propynyloxy)-2-amino-3-propanol, leur preparation et leur application en therapeutique
FR2552083B1 (fr) * 1983-09-15 1986-05-09 Cerm Cent Europ Rech Mauvernay Derives de (alkynyloxy-3 hydroxy-2-propyl)-4 piperazinyl-1 n-phenyl acetamide, leur preparation et leur application en therapeutique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB948766A (en) * 1959-10-20 1964-02-05 May & Baker Ltd Trifluoromethylphenylpiperazine derivatives
CA956632A (en) * 1969-05-16 1974-10-22 Yoshitomi Pharmaceutical Industries Phenoxy-aminopropanol derivatives

Also Published As

Publication number Publication date
FR2173869B1 (de) 1975-12-26
US3884923A (en) 1975-05-20
DE2318025A1 (de) 1973-10-25
BE798067A (fr) 1973-07-31
IL42030A (en) 1975-12-31
GB1382559A (en) 1975-02-05
OA04927A (fr) 1980-10-31
NL7305248A (de) 1973-10-16
AU5444473A (en) 1974-10-17
DE2366224C2 (de) 1980-05-29
DE2366224B1 (de) 1979-09-20
DE2318025C2 (de) 1981-11-12
IL42030A0 (en) 1973-06-29
JPS4914480A (de) 1974-02-07
ES413487A1 (es) 1976-06-01
JPS541316B2 (de) 1979-01-23
NL177113C (nl) 1985-08-01
CH570984A5 (de) 1975-12-31
ATA320373A (de) 1975-07-15
ZA732457B (en) 1974-10-30
FR2173869A1 (de) 1973-10-12
NL177113B (nl) 1985-03-01
CA1019740A (en) 1977-10-25

Similar Documents

Publication Publication Date Title
AT317201B (de) Verfahren zur Herstellung neuer Imidazolderivate und ihrer Salze
AT338271B (de) Verfahren zur herstellung von neuen piperazinderivaten sowie deren salzen
AT332406B (de) Verfahren zur herstellung neuer chinolinverbindungen und ihrer salze
AT310738B (de) Verfahren zur Herstellung neuer Benzimidazol-derivate und ihrer Salze
AT336006B (de) Verfahren zur herstellung neuer imidazolinderivate und ihrer salze
AT323152B (de) Verfahren zur herstellung neuer indolderivate und ihrer salze
AT326117B (de) Verfahren zur herstellung neuer indolderivate und ihrer salze
AT314531B (de) Verfahren zur Herstellung neuer 2-Phenylamino-imidazolidine und ihrer Salze
AT321293B (de) Verfahren zur Herstellung neuer Benzimidazolderivate und ihrer Salze
ATA943273A (de) Verfahren zur herstellung neuer substituierter 2-phenylamino-imidazoline und ihrer saeureadditionssalze
AT313894B (de) Verfahren zur Herstellung neuer Isoindolinonderivate und ihrer Salze
ATA548873A (de) Verfahren zur herstellung neuer oxindolderivate und ihrer salze
ATA306573A (de) Verfahren zur herstellung neuer thiophenderivate und ihrer salze
AT328435B (de) Verfahren zur herstellung neuer imidazolderivate und ihrer salze
ATA320373A (de) Verfahren zur herstellung neuer piperazinderivate und ihrer salze
AT299199B (de) Verfahren zur Herstellung neuer Benzodioxanderivate und ihrer Salze
AT325035B (de) Verfahren zur herstellung neuer indolderivate und ihrer salze
AT334903B (de) Verfahren zur herstellung neuer piperazin-derivate und ihrer salze
AT312593B (de) Verfahren zur Herstellung neuer Cumarinderivate und ihrer Salze
AT307401B (de) Verfahren zur Herstellung neuer Dibenzofuranderivate und ihrer Salze
AT339891B (de) Verfahren zur herstellung neuer isoindolinderivate und ihrer salze
CH556840A (de) Verfahren zur herstellung neuer indolderivate und ihrer salze.
AT334904B (de) Verfahren zur herstellung neuer piperazin-derivate und ihrer salze
AT324334B (de) Verfahren zur herstellung neuer beta-amino-acrylsäure-derivate und deren salze
AT308090B (de) Verfahren zur Herstellung neuer Cumarinderivate und ihrer Salze

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
ELJ Ceased due to non-payment of the annual fee